MX2022011131A - Nuevo uso y metodo de tratamiento. - Google Patents
Nuevo uso y metodo de tratamiento.Info
- Publication number
- MX2022011131A MX2022011131A MX2022011131A MX2022011131A MX2022011131A MX 2022011131 A MX2022011131 A MX 2022011131A MX 2022011131 A MX2022011131 A MX 2022011131A MX 2022011131 A MX2022011131 A MX 2022011131A MX 2022011131 A MX2022011131 A MX 2022011131A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- new use
- pharmaceutical composition
- administration
- active ingredient
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona una composición farmacéutica que comprende como principio activo un hidrogel inversamente termorreversible, para la administración en el ojo de sujetos mamíferos. En particular, se refiere a una composición farmacéutica para su uso en, y a un método para, el tratamiento oftálmico de la enfermedad del ojo seco.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20162821 | 2020-03-12 | ||
PCT/EP2021/056314 WO2021180913A1 (en) | 2020-03-12 | 2021-03-12 | New use and method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022011131A true MX2022011131A (es) | 2022-11-14 |
Family
ID=69810711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022011131A MX2022011131A (es) | 2020-03-12 | 2021-03-12 | Nuevo uso y metodo de tratamiento. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20230131227A1 (es) |
EP (1) | EP4117622A1 (es) |
JP (1) | JP2023517317A (es) |
KR (1) | KR20220152244A (es) |
CN (1) | CN115297839A (es) |
AU (1) | AU2021233161A1 (es) |
BR (1) | BR112022018060A2 (es) |
CA (1) | CA3170370A1 (es) |
IL (1) | IL296120A (es) |
MX (1) | MX2022011131A (es) |
TW (1) | TW202200208A (es) |
WO (1) | WO2021180913A1 (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
LT2689774T (lt) | 2011-03-21 | 2019-03-25 | Broda Technologies Co., Ltd | Atvirkščiai termiškai grįžtama hidrogelio kompozicija |
US20170112936A1 (en) * | 2014-05-23 | 2017-04-27 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions comprising gels and methods for fabricating thereof |
EP3525885B1 (en) * | 2016-10-12 | 2022-01-26 | PS Therapy Ltd. | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
CN108295318B (zh) * | 2018-01-31 | 2021-07-06 | 西安泰科迈医药科技股份有限公司 | 一种温敏可注射型泪道栓及其制备方法 |
-
2021
- 2021-03-05 TW TW110107837A patent/TW202200208A/zh unknown
- 2021-03-12 BR BR112022018060A patent/BR112022018060A2/pt unknown
- 2021-03-12 AU AU2021233161A patent/AU2021233161A1/en active Pending
- 2021-03-12 JP JP2022553599A patent/JP2023517317A/ja active Pending
- 2021-03-12 CA CA3170370A patent/CA3170370A1/en active Pending
- 2021-03-12 CN CN202180018900.7A patent/CN115297839A/zh active Pending
- 2021-03-12 US US17/907,953 patent/US20230131227A1/en active Pending
- 2021-03-12 EP EP21710328.2A patent/EP4117622A1/en active Pending
- 2021-03-12 IL IL296120A patent/IL296120A/en unknown
- 2021-03-12 WO PCT/EP2021/056314 patent/WO2021180913A1/en unknown
- 2021-03-12 KR KR1020227033688A patent/KR20220152244A/ko active Search and Examination
- 2021-03-12 MX MX2022011131A patent/MX2022011131A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL296120A (en) | 2022-11-01 |
JP2023517317A (ja) | 2023-04-25 |
TW202200208A (zh) | 2022-01-01 |
US20230131227A1 (en) | 2023-04-27 |
WO2021180913A1 (en) | 2021-09-16 |
EP4117622A1 (en) | 2023-01-18 |
CA3170370A1 (en) | 2021-09-16 |
KR20220152244A (ko) | 2022-11-15 |
BR112022018060A2 (pt) | 2022-10-25 |
AU2021233161A1 (en) | 2022-09-29 |
CN115297839A (zh) | 2022-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017158366A3 (en) | Ophthalmic delivery device and ophthalmic drug compositions | |
WO2011053801A3 (en) | Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye | |
WO2016042163A3 (en) | Ophthalmic drug compositions | |
JP2019532931A (ja) | 眼瞼炎の治療に使用するための医薬組成物 | |
BRPI0608152A2 (pt) | formulações para tratamento ocular | |
MX2021010058A (es) | Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel. | |
RU2017129247A (ru) | Способы и композиции для лечения болезни сухого глаза и других глазных заболеваний | |
MX2013011314A (es) | Tratamientos oftalmicos. | |
MX2011008616A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
ATE428401T1 (de) | Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten | |
MX2020005217A (es) | Composicion oftalmica y dispositivo de administracion de la misma. | |
MX2019013799A (es) | Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo. | |
PH12016501357B1 (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
RU2018114926A (ru) | Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения | |
AR088585A1 (es) | Un medicamento para tratar la enfermedad del ojo anterior | |
ATE529417T1 (de) | 3',4',5-trimethoxyflavonderivate als die schleimsekretion stimulierendes mittel, entsprechendes verfahren und pharmazeutische zusammensetzung, die diese enthält | |
MX355770B (es) | Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico. | |
EP4279063A3 (en) | Ophthalmic pharmaceutical composition, preparation method therefor and application thereof | |
NZ766141A (en) | Isoxazoline parasiticide formulations and methods for treating blepharitis | |
WO2016060917A3 (en) | Formulations for histatin therapeutics | |
BR112014009761B8 (pt) | Composição de reticulação melhorada entregue por iontoforese, útil para o tratamento de ceratocone | |
MX2023009352A (es) | Metodos para la administracion oftalmica de roflumilast. | |
WO2021262916A8 (en) | Pharmaceutical formulations of griseofulvin for long-term ocular delivery | |
MX2022011131A (es) | Nuevo uso y metodo de tratamiento. | |
WO2017152129A3 (en) | Treatment of glaucoma and/or retinal diseases and formulations useful therefore |